StockData

China Pharma Holdings, Inc. (CPHI) stock

CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.54−0.01 (-1.43%)

Close on Nov 11, 2026Market cap $23.37MP/E –Yield –

Earnings

China Pharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of China Pharma's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2016ended Dec 31, 2016Mar 31, 2017before the open–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

China Pharma has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When China Pharma puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases China Pharma filed with the SEC as exhibits to Form 8-K or 6-K

  1. PRESS RELEASE DATED AS OF JULY 22, 2026
    News
  2. PRESS RELEASE, DATED APRIL 4, 2025
    Update
  3. PRESS RELEASE, DATED FEBRUARY 23, 2024.
    Update
  4. PRESS RELEASE, DATED FEBRUARY 24, 2023.
    Update

See a number that looks wrong?